TSPY1 and prostate carcinoma: Initial studies demonstrate that TSPY transcription levels can be raised by androgene administration in androgen-responsive human prostate cancer cell line LNCaP, suggesting that TSPY expression could be regulated by androgens and its receptor within the testis and the prostate [54,55].